Search

everythinglearnresearchcommunity

for

Search:↓

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Adipose-derived stem cells can help repair tissue in lipodystrophy patients.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

The treatments stopped hair regrowth in mice.

IL-17 and certain immune cells are linked to more severe alopecia areata.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Targeting specific T cells may help treat alopecia areata.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Scientists identified a unique type of human skin stem cell that could help with tissue repair.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

Abatacept may help some people with alopecia areata regrow hair.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.